Delivery Order SPE2DB24D2205-SPE2DB25FEGFS
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $1,023.62 firm fixed-price delivery order for Dexcom G7 sensors, with an ultimate completion date of September 5, 2025. This competitively awarded contract, issued on September 4, 2025, represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,498.10 to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. This competitively awarded, firm fixed-price contract has an ultimate completion date of August 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction under AmerisourceBergen's broader federal medical supply portfolio and reflects...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,891.14 to AmerisourceBergen Drug Corp for Dexcom G7 sensors. The contract, which became effective on June 18, 2025, with an ultimate completion date of June 20, 2025, represents a firm fixed price procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order under its existing Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,474.88 to AmerisourceBergen Drug Corp for the supply of Dexcom G7 sensors. This firm fixed price, non-competitive delivery order was issued on August 8, 2025, with an ultimate completion date of August 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's substantial role as a federal medical supply provider,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors. This firm fixed-price contract, awarded on August 20, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The award carries no set-aside designation and will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $2,280.80 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of August 8, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,659.79 in Dexcom G7 sensors with a completion deadline of September 30, 2025. This is a firm fixed price delivery order with no set-aside designation, representing a competitive award under the company's larger pharmaceutical supply relationship with DLA. The award is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors valued at $2,845.71. This firm fixed-price contract, executed on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The award...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,131.33 to AmerisourceBergen Drug Corp for Dexcom G7 sensors. This non-competitive delivery order, issued on September 19, 2025, represents a firm fixed price purchase with an ultimate completion date of September 22, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency has awarded a delivery order valued at $1,694.39 to AmerisourceBergen Drug Corp for Dexcom G7 sensors. This firm fixed price, competitively awarded contract was issued on September 22, 2025, with an ultimate completion date of September 23, 2025. The delivery will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGFSDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,163.54 to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. This firm fixed price contract, awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made on a non-set-aside, competitive basis and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's $999,999,999.00 prime IDC with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems worldwide. AmerisourceBergen is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a broad portfolio of pharmaceutical products and medical devices to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Dexcom G7 sensors acquired under this delivery order support diabetes management and chronic disease care capabilities within the military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/14/25 |